Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech
Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery. For privately held companies, Isomorphic’s raise is the second-largest in biotech history ...
Demis Hassabis, Isomorphic Labs CEO (Chris Jung/NurPhoto via AP Images) May 12, 2026 11:42 AM EDT FinancingAI Five burning questions for Isomorphic after its mammoth $2B+ raise Andrew Dunn Senior Biopharma Correspondent Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery. For privately … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that